You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

James C. Mullen

Chief Executive Officer at DPx Holdings BV
Relationship Science aggregates deep and verified information on over 6 million influential decision makers and the over 1.5 million organizations with which they are associated. From this data, we create a "business social graph" that highlights who knows whom. Here are James C. Mullen's strongest connections.

People Most Closely Connected to James C. Mullen

Click the names below to expand relationship details.
George Scangos
Limited Partner at Lead Edge Capital Management
Cecil B. Pickett
Member-Medicine Institute at National Academy of Sciences
Michel Vounatsos
Director & Chief Executive Officer at Biogen, Inc.
Patrick J. Sullivan
Chairman of the Board & Chief Executive Officer at Insulet Corp.
Robert Perez
Founder at Vineyard Sound Advisors
Stuart Grant
Chief Financial Officer & Executive Vice President at DPx Holdings BV
Michel Lagarde
Senior Vice President & President, Pharma Services at Thermo Fisher Scientific, Inc.
Peter Thomas Bigelow
Chief Executive Officer at xCell Strategic Consulting
Michael J. Lehmann
Head-Drug Product Sales & Marketing at DPx Holdings BV
Hans Peter Hasler
Chief Operating Officer at Elan Pharmaceuticals Plc
Rebecca Holland New
Chief Human Resources Officer & Senior Vice President-Communications at DPx Holdings BV
Harry R. Gill III
Senior Vice President-President, Quality & Operational Excellence at DPx Holdings BV
Daniel Agroskin
Partner at JLL Partners, Inc.
Michael Lytton
Former General Counsel & Executive Vice President, Corporate Development & Strategy at Patheon, Inc.
Tony van Bijleveld
General Manager at DPx Holdings BV
James R. Tobin
Former President & Chief Executive Officer at Boston Scientific Corporation
Paul J. Clancy
Executive Vice President & Chief Financial Officer at Alexion Pharmaceuticals, Inc.
Burt Adelman
Senior Advisor at Novo Ventures (US), Inc.
1,535 more connections are available with a RelSci Professional subscription.